Matthew M. Walsh - May 4, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Financial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Stock symbol
OGN
Transactions as of
May 4, 2024
Transactions value $
-$80,264
Form type
4
Date filed
5/7/2024, 04:05 PM
Previous filing
Apr 3, 2024
Next filing
May 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +8.31K +9.88% $0.00 92.4K May 4, 2024 Direct
transaction OGN Common Stock Tax liability -$80.3K -4.09K -4.43% $19.61 88.3K May 4, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -8.31K -100% $0.00* 0 May 4, 2024 Common Stock 8.31K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2 On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested.